Video Shorts

0:54
Why Global Science Innovation is Shifting to Asia
21 hours ago
by
Mike Hollan(+1 more)

1:29
Exec on Execs: Identifying the Gaps
3 days ago
by
Mike Hollan

1:22
Market Movers RX: Gilead Sciences Leads Gainers
6 days ago
by
Nicholas Jacobus

0:57
Targeted Resilience: A Smarter Tariff Response
7 days ago
by
Nicholas Jacobus(+1 more)

0:52
The 340B Drug Pricing Secret
8 days ago
by
Mike Hollan(+1 more)

2:23
Exec on Execs: Fixing What's Broken
10 days ago
by
Mike Hollan

1:32
Market Movers RX: Moderna Leads Gainers
13 days ago
by
Nicholas Jacobus

0:55
Why Multiple Databases Are Killing Your Business Efficiency
15 days ago
by
Mike Hollan(+1 more)

1:34
Exec on Execs: An Industry Facing Change
17 days ago
by
Mike Hollan

0:56
Biotech Security: A New National Defense Priority
22 days ago
by
Mike Hollan(+1 more)

1:29
Exec on Execs: China's Rise in Biotech Investment
24 days ago
by
Mike Hollan

1:13
Market Movers Rx: Iqvia Leads Gainers
a month ago
by
Nicholas Jacobus

1:53
Execs on Exec: GLP-1 Coverage Gaps, China's Supply Chain, and the Clinical Trial Competitiveness Problem
a month ago
by
Mike Hollan

1:03
Why U.S. Biotech Regulation is Slow
a month ago
by
Mike Hollan(+1 more)

1:19
Market Movers Rx: AbbVie Leads Gainers
a month ago
by
Nicholas Jacobus

0:50
Why Your GLP-1 Strategy Is Failing
a month ago
by
Mike Hollan(+1 more)

0:46
Why U.S. Manufacturing is Losing Its Competitive Edge
a month ago
by
Nicholas Jacobus(+1 more)

0:54
Why We Need Better Drugs, Not Just More Drugs
a month ago
by
Mike Hollan(+1 more)

1:21
Market Watch RX: Gilead Joins Top Gainers
2 months ago
by
Nicholas Jacobus

0:27
The Key to AI Scale-Up
2 months ago
by
Michael Christel(+1 more)

1:14
Market Watch Rx: Zoetis Shares Slid
2 months ago
by
Nicholas Jacobus

0:51
The Billions Invested in Domestic Manufacturing
2 months ago
by
Mike Hollan(+1 more)

0:56
Big FDA & EMA Changes for Rare Disease Therapies
2 months ago
by
Mike Hollan(+1 more)

0:53
The Challenges Bringing Pharma and Biotech Manufacturing Back to the U.S.
2 months ago
by
Mike Hollan(+1 more)

0:36
Why Employers Are Blocking Obesity Drugs?
2 months ago
by
Nicholas Jacobus(+1 more)

1:04
How Novavax’s Protein-Based Vaccine Technology Works
2 months ago
by
Mike Hollan(+1 more)

1:18
Market Watch Rx: Medtronic Leads Gainers
2 months ago
by
Nicholas Jacobus

0:47
Tackling Duplicate Discounts
3 months ago
by
Michael Christel(+1 more)

0:59
Why Basket Trials Are Changing Rare Disease Research
3 months ago
by
Mike Hollan(+1 more)

1:06
Market Watch Rx: Cigna Joins Top Gainers
3 months ago
by
Nicholas Jacobus
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
FDA Approves Daraxonrasib as First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer
4
Pharmaceutical Executive Daily: Haisco Licenses Preclinical Immunology Asset to Sentivera
5
